JPL Wealth Management »

First Tracks Biotherapeutics shares owned by JPL Wealth Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by JPL Wealth Management from 13F filings

Historical chart of JPL Wealth Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by JPL Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by JPL Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $725 36 20.14

More positions owned by JPL Wealth Management

Spdr Series Trust St Str P500etf (SPYM)
UnitedHealth (UNH)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Ea Series Trust Alpha Architect (CAOS)
Caterpillar (CAT)
Ea Series Trust Alpha Architect (AAEQ)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ea Series Trust Us Quan Momentum (QMOM)
Ishares Tr Ishares Semicdtr (SOXX)

View all positions for JPL Wealth Management

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics